Literature DB >> 1324035

Fungemia caused by Hansenula anomala: successful treatment with fluconazole.

S Hirasaki1, T Ijichi, N Fujita, S Araki, H Gotoh, M Nakagawa.   

Abstract

Fungemia, due to Hansenula anomala, developed in an adult patient with small cell lung cancer who received anti-cancer chemotherapy and plasmapheresis for a sensori-motor neuropathy complication. Treatment with intravenous infusion of fluconazole in addition to the removal of the central venous catheter was successful in treating the fungemia. Pathogenic Hansenula anomala infections are rare, but reports of this infection have been increasing. The use of fluconazole treatment for this infection has not been reported in the literature, and this is the first case of an adult infection of Hansenula anomala in Japan.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324035     DOI: 10.2169/internalmedicine.31.622

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Hansenula anomala outbreak at a surgical intensive care unit: a search for risk factors.

Authors:  S Kalenic; M Jandrlic; V Vegar; N Zuech; A Sekulic; E Mlinaric-Missoni
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

Review 2.  New and emerging yeast pathogens.

Authors:  K C Hazen
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

3.  In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.

Authors:  D J Diekema; S A Messer; L B Boyken; R J Hollis; J Kroeger; S Tendolkar; M A Pfaller
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.